Niagen Bioscience, Inc. (FRA:OCD1)
5.35
+0.10 (1.90%)
At close: Dec 4, 2025
Niagen Bioscience Market Cap
Niagen Bioscience has a market cap or net worth of €444.05 million as of December 5, 2025. Its market cap has decreased by -18.32% in one year.
Market Cap
444.05M
Enterprise Value
391.54M
Revenue
106.29M
Ranking
n/a
PE Ratio
25.50
Stock Price
€5.35
Market Cap Chart
Since June 24, 2008, Niagen Bioscience's market cap has increased from 67.39M to 444.05M, an increase of 558.87%. That is a compound annual growth rate of 11.40%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.46B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |